{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:43:46Z","timestamp":1781822626708,"version":"3.54.5"},"reference-count":128,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:p>Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is characterized by cortisol and in some cases aldosterone deficiency associated with androgen excess. Goals of treatment are to replace deficient hormones and control androgen excess, while avoiding the adverse effects of exogenous glucocorticoid. Over the last 5 years, cohorts of adults with CAH due to 21-hydroxylase deficiency from Europe and the United States have been described, allowing us to have a better knowledge of long-term complications of the disease and its treatment. Patients with CAH have increased mortality, morbidity and risk for infertility and metabolic disorders. These comorbidities are due in part to the drawbacks of the currently available glucocorticoid therapy. Consequently, novel therapies are being developed and studied in an attempt to improve patient outcomes. New management strategies in the care of pregnancies at risk for congenital adrenal hyperplasia using fetal sex determination and dexamethasone have also been described, but remain a subject of debate. We focused the present overview on the data published in the last 5 years, concentrating on studies dealing with cardiovascular risk, fertility, treatment and prenatal management in adults with classic CAH to provide the reader with an updated review on this rapidly evolving field of knowledge.<\/jats:p>","DOI":"10.1530\/eje-16-0888","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T02:30:24Z","timestamp":1485225024000},"page":"R167-R181","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":49,"title":["MANAGEMENT OF ENDOCRINE DISEASE: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: update on the management of adult patients and prenatal treatment"],"prefix":"10.1093","volume":"176","author":[{"given":"Anne","family":"Bachelot","sequence":"first","affiliation":[{"name":"1AP-HPIE3M, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Department of Endocrinology and Reproductive Medicine and Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance, Centre de R\u00e9f\u00e9rence des Pathologies Gyn\u00e9cologiques Rares, ICAN, Paris, France"},{"name":"2 UPMC Universit\u00e9 Pierre et Marie CurieUniv Paris 06, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Grouthier","sequence":"additional","affiliation":[{"name":"1AP-HPIE3M, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Department of Endocrinology and Reproductive Medicine and Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance, Centre de R\u00e9f\u00e9rence des Pathologies Gyn\u00e9cologiques Rares, ICAN, Paris, France"},{"name":"2 UPMC Universit\u00e9 Pierre et Marie CurieUniv Paris 06, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Courtillot","sequence":"additional","affiliation":[{"name":"1AP-HPIE3M, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Department of Endocrinology and Reproductive Medicine and Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance, Centre de R\u00e9f\u00e9rence des Pathologies Gyn\u00e9cologiques Rares, ICAN, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Dulon","sequence":"additional","affiliation":[{"name":"1AP-HPIE3M, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Department of Endocrinology and Reproductive Medicine and Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance, Centre de R\u00e9f\u00e9rence des Pathologies Gyn\u00e9cologiques Rares, ICAN, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Touraine","sequence":"additional","affiliation":[{"name":"1AP-HPIE3M, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Department of Endocrinology and Reproductive Medicine and Centre de R\u00e9f\u00e9rence des Maladies Endocriniennes Rares de la Croissance, Centre de R\u00e9f\u00e9rence des Pathologies Gyn\u00e9cologiques Rares, ICAN, Paris, France"},{"name":"2 UPMC Universit\u00e9 Pierre et Marie CurieUniv Paris 06, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2017022117115972000_176.4.R167.1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4158\/EP14474.RA","article-title":"The classic and nonclassic concenital adrenal hyperplasias","volume":"21","author":"Auchus","year":"2015","journal-title":"Endocrine Practice"},{"key":"2017022117115972000_176.4.R167.2","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"12","author":"New","year":"2013","journal-title":"PNAS"},{"key":"2017022117115972000_176.4.R167.3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2013.239","article-title":"Treatment and health outcomes in adults with congenital adrenal hyperplasia","volume":"10","author":"Han","year":"2014","journal-title":"Nature Reviews Endocrinology"},{"key":"2017022117115972000_176.4.R167.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0917"},{"key":"2017022117115972000_176.4.R167.5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0978"},{"key":"2017022117115972000_176.4.R167.6","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2102"},{"key":"2017022117115972000_176.4.R167.8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","article-title":"Clinical outcomes in the management of congenital adrenal hyperplasia","volume":"41","author":"Falhammar","year":"2012","journal-title":"Endocrine"},{"key":"2017022117115972000_176.4.R167.9","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0877"},{"key":"2017022117115972000_176.4.R167.10","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1210\/jc.2014-4124","article-title":"Clinical outcome, hormonal status, gonadotrope axis, and testicular function in 219 adult men born with classic 21-hydroxylase deficiency. a French national survey","volume":"100","author":"Bouvattier","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.11","doi-asserted-by":"crossref","first-page":"E1153","DOI":"10.1210\/jc.2014-4033","article-title":"Increased abdominal adiposity in adolescents and young adults with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"100","author":"Kim","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000353762","article-title":"Obesity and familial predisposition are significant determining factors of an adverse metabolic profile in young patients with congenital adrenal hyperplasia","volume":"80","author":"Moreira","year":"2013","journal-title":"Hormone Research in P\u00e6diatrics"},{"key":"2017022117115972000_176.4.R167.13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2009.03690.x","article-title":"Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia?","volume":"73","author":"Mooij","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"2017022117115972000_176.4.R167.14","unstructured":"Ubertini G Bizzarri C Grossi A Gimigliano F Rav\u00e0 L Fintini D Cappa M. Blood pressure and left ventricular characteristics in young patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. International Journal of Pediatric Endocrinology 2009 383610. (doi:10.1155\/2009\/383610)"},{"key":"2017022117115972000_176.4.R167.15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1711"},{"key":"2017022117115972000_176.4.R167.16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1350"},{"key":"2017022117115972000_176.4.R167.17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jc.2014-1805","article-title":"Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia","volume":"100","author":"Marra","year":"2015","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.18","first-page":"1806","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"27","author":"Cutler GB","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"2017022117115972000_176.4.R167.19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1515\/JPEM.2004.17.8.1089","article-title":"24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia \u2013 a preliminary report","volume":"17","author":"De Silva","year":"2004","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1069"},{"key":"2017022117115972000_176.4.R167.21","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0196"},{"key":"2017022117115972000_176.4.R167.22","doi-asserted-by":"crossref","first-page":"e24204","DOI":"10.1371\/journal.pone.0024204","article-title":"Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile","volume":"6","author":"Mooij","year":"2011","journal-title":"PLoS ONE"},{"key":"2017022117115972000_176.4.R167.23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01757.x"},{"key":"2017022117115972000_176.4.R167.24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/cen.12265","article-title":"Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"80","author":"Subbarayan","year":"2014","journal-title":"Clinical Endocrinology"},{"key":"2017022117115972000_176.4.R167.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2007.11.011"},{"key":"2017022117115972000_176.4.R167.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04309.x"},{"key":"2017022117115972000_176.4.R167.27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s40618-014-0148-8","article-title":"Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia","volume":"37","author":"Amr","year":"2014","journal-title":"Journal of Endocrinological Investigation"},{"key":"2017022117115972000_176.4.R167.28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000444169","article-title":"Carotid intima-media thickness is associated with increased androgens in adolescents and young adults with classical congenital adrenal hyperplasia","volume":"85","author":"Kim","year":"2016","journal-title":"Hormone Research in P\u00e6diatrics"},{"key":"2017022117115972000_176.4.R167.29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03346751","article-title":"Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasia","volume":"36","author":"Wasniewska","year":"2013","journal-title":"Journal of Endocrinological Investigation"},{"key":"2017022117115972000_176.4.R167.30","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/jc.2016-1877","article-title":"Complex influence of gonadotropins and sex steroid hormones on QT interval duration","volume":"101","author":"Abehsira","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.31","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.32","doi-asserted-by":"crossref","unstructured":"Moreira RP Gomes LG Mendonca BB Bachega TA. Impact of glucocorticoid receptor gene polymorphisms on the metabolic profile of adult patients with the classical form of 21-hydroxylase deficiency. PLos ONE 2012 7 e44893. (doi:10.1371\/journal.pone.0044893)","DOI":"10.1371\/journal.pone.0044893"},{"key":"2017022117115972000_176.4.R167.33","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1757"},{"key":"2017022117115972000_176.4.R167.34","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","article-title":"Congenital adrenal hyperplasia","volume":"18","author":"Merke","year":"2005","journal-title":"Lancet"},{"key":"2017022117115972000_176.4.R167.35","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0454"},{"key":"2017022117115972000_176.4.R167.36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsbmb.2016.03.021","article-title":"Surgical outcomes and complications of reconstructive surgery in the female congenital adrenal hyperplasia patient: What every endocrinologist should know.","volume":"165","author":"Wang","year":"2017","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"2017022117115972000_176.4.R167.37","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.juro.2014.11.008","article-title":"Congenital adrenal hyperplasia: current surgical management at academic medical centers in the United States","volume":"193","author":"Sturm","year":"2015","journal-title":"Journal of Urology"},{"key":"2017022117115972000_176.4.R167.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02410.x"},{"key":"2017022117115972000_176.4.R167.39","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.juro.2015.12.053","article-title":"Nerve sparing clitoroplasty is an option for adolescent and adult female patients with congenital adrenal hyperplasia and clitoral pain following prior clitoral recession or incomplete reduction","volume":"195","author":"Reifsnyder","year":"2016","journal-title":"Journal of Urology"},{"key":"2017022117115972000_176.4.R167.40","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.eururo.2007.02.068","article-title":"Passerini-glazel feminizing genitoplasty: modifications in 17 years of experience with 82 cases","volume":"52","author":"Lesma","year":"2007","journal-title":"European Urology"},{"key":"2017022117115972000_176.4.R167.41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jpurol.2016.04.001","article-title":"Surger in disorders of sex development (DSD) with a gender isssue: if (why), when, and how?","volume":"12","author":"Mouriquand","year":"2016","journal-title":"Journal of Pediatric Urology"},{"key":"2017022117115972000_176.4.R167.42","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den118"},{"key":"2017022117115972000_176.4.R167.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03563.x"},{"key":"2017022117115972000_176.4.R167.44","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1210\/jc.2013-3326","article-title":"Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia: epidemiological studies in a nonbiased national cohort in Sweden","volume":"99","author":"Strandqvist","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1929"},{"key":"2017022117115972000_176.4.R167.46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ando.2012.09.005","article-title":"Adrenal rest tissue in gonads of patients with classical congenital adrenal hyperplasia: multicenter study of 45 French male patients","volume":"73","author":"Pierre","year":"2012","journal-title":"Annales d\u2019Endocrinologie"},{"key":"2017022117115972000_176.4.R167.47","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000365570","article-title":"Kamphuis-van Ulzen K & de Korte CL. Increased prevalence of testicular adrenal rest tumours during adolescence in congenital adrenal hyperplasia","volume":"82","author":"Claahsen-van der Grinten","year":"2014","journal-title":"Hormone Research in P\u00e6diatrics"},{"key":"2017022117115972000_176.4.R167.48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/cen.12033","article-title":"Prevalence and long-term follow-up outcomes of testicular adrenal rest tumours in children and adolescent males with congenital adrenal hyperplasia","volume":"78","author":"Aycan","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"2017022117115972000_176.4.R167.49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1414"},{"key":"2017022117115972000_176.4.R167.50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.6065\/apem.2015.20.3.155","article-title":"Clinical manifestations of testicular adrenal rest tumor in males with congenital adrenal hyperplasia","volume":"20","author":"Yu","year":"2015","journal-title":"Annals of Pediatric and Endocrinology Metabolism"},{"key":"2017022117115972000_176.4.R167.51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/and.12416","article-title":"Testicular adrenal rest tumours in young adult males with congenital adrenal hyperplasia: prevalence and impact on testicular function","volume":"48","author":"Chihaoui","year":"2016","journal-title":"Andrologia"},{"key":"2017022117115972000_176.4.R167.52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3181"},{"key":"2017022117115972000_176.4.R167.53","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2036"},{"key":"2017022117115972000_176.4.R167.54","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1056\/NEJMc1410041","article-title":"Mitotane for 21-hydroxylase deficiency in an infertile man","volume":"20","author":"Bry-Gauillard","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"2017022117115972000_176.4.R167.55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/cen.13001","article-title":"Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency","volume":"84","author":"King","year":"2016","journal-title":"Clinical Endocrinology"},{"key":"2017022117115972000_176.4.R167.56","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-13-0449"},{"key":"2017022117115972000_176.4.R167.57","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0828"},{"key":"2017022117115972000_176.4.R167.58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12020-013-0161-2","article-title":"Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia","volume":"47","author":"Falhammar","year":"2014","journal-title":"Endocrine"},{"key":"2017022117115972000_176.4.R167.59","doi-asserted-by":"crossref","first-page":"469289","DOI":"10.1155\/2014\/469289","article-title":"Sexual well-being in adult male patients with congenital adrenal hyperplasia","volume":"2014","author":"Dudzi\u0144ska","year":"2014","journal-title":"International Journal of Endocrinology"},{"key":"2017022117115972000_176.4.R167.60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.beem.2014.11.002","article-title":"Substitution therapy in adult patients with congenital adrenal hyperplasia","volume":"29","author":"Reisch","year":"2015","journal-title":"Best Practice and Research. Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MED.0000000000000256","article-title":"Novel treatment strategies in congenital adrenal hyperplasia","volume":"23","author":"Turcu","year":"2016","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"2017022117115972000_176.4.R167.62","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0170"},{"key":"2017022117115972000_176.4.R167.63","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1926"},{"key":"2017022117115972000_176.4.R167.64","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-1114"},{"key":"2017022117115972000_176.4.R167.65","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0064"},{"key":"2017022117115972000_176.4.R167.66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03636.x"},{"key":"2017022117115972000_176.4.R167.67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3809"},{"key":"2017022117115972000_176.4.R167.68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02544.x"},{"key":"2017022117115972000_176.4.R167.69","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/jc.2013-4253","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison\u2019s disease: a randomized clinical trial","volume":"99","author":"Oksnes","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.70","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2433"},{"key":"2017022117115972000_176.4.R167.71","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12470"},{"key":"2017022117115972000_176.4.R167.72","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1210\/jc.2016-1916","article-title":"A phase 2 study of continuous subcutaneous hydrocortisone infusion in adults with congenital adrenal hyperplasia","volume":"101","author":"Nella","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000295722","article-title":"Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy","volume":"74","author":"Tiosano","year":"2010","journal-title":"Hormone Research in P\u00e6diatrics"},{"key":"2017022117115972000_176.4.R167.74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2298"},{"key":"2017022117115972000_176.4.R167.75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.reprotox.2014.01.008","article-title":"Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines","volume":"45","author":"Gentilin","year":"2014","journal-title":"Reproductive Toxicology"},{"key":"2017022117115972000_176.4.R167.76","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0368"},{"key":"2017022117115972000_176.4.R167.77","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71205-7"},{"key":"2017022117115972000_176.4.R167.78","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1258"},{"key":"2017022117115972000_176.4.R167.79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fendo.2016.00101","article-title":"ACTH antagonists","volume":"7","author":"Clark","year":"2016","journal-title":"Frontiers in Endocrinology"},{"key":"2017022117115972000_176.4.R167.80","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2015-3574","article-title":"Single-dose study of a corticotropin-releasing factor receptor-1 antagonist in women with 21-hydroxylase deficiency","volume":"101","author":"Turcu","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.81","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(84)80310-8"},{"key":"2017022117115972000_176.4.R167.82","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jama.1985.03350310097034","article-title":"Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia","volume":"15","author":"Evans","year":"1985","journal-title":"JAMA"},{"key":"2017022117115972000_176.4.R167.83","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(98)00067-8"},{"key":"2017022117115972000_176.4.R167.84","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.12.5651"},{"key":"2017022117115972000_176.4.R167.85","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80128-3"},{"key":"2017022117115972000_176.4.R167.86","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-1-39"},{"key":"2017022117115972000_176.4.R167.87","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-5-969"},{"key":"2017022117115972000_176.4.R167.88","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1203\/00006450-199608000-00021","article-title":"Serum cortisol, dehydroepiandrosterone sulfate, and steroid-binding globulins in preterm neonates: effect of gestational age and dexamethasone therapy","volume":"40","author":"Kari","year":"1996","journal-title":"Pediatric Research"},{"key":"2017022117115972000_176.4.R167.89","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-0528.2003.00040.x"},{"key":"2017022117115972000_176.4.R167.90","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1210\/jc.2013-2895","article-title":"New management strategy of pregnancies at risk of congenital adrenal hyperplasia using fetal sex determination in maternal serum: French cohort of 258 cases (2002-2011)","volume":"99","author":"Tardy-Guidollet","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.91","doi-asserted-by":"publisher","DOI":"10.1080\/07435808909039101"},{"key":"2017022117115972000_176.4.R167.92","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.1.117"},{"key":"2017022117115972000_176.4.R167.93","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90125-G"},{"key":"2017022117115972000_176.4.R167.94","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.7.2014"},{"key":"2017022117115972000_176.4.R167.95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.11.3872"},{"key":"2017022117115972000_176.4.R167.96","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.ten.0000081690.21823.af","article-title":"Prenatal therapy in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: retrospective follow-up study of 253 treated pregnancies in 215 families","volume":"13","author":"Forest","year":"2003","journal-title":"Endocrinologist"},{"key":"2017022117115972000_176.4.R167.97","first-page":"495","article-title":"The surgical challenges of disorders of sex development (DSD)","volume":"63","author":"Gorduza","year":"2010","journal-title":"Archivos Espanoles de Urologia"},{"key":"2017022117115972000_176.4.R167.98","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2265.2010.03826.x","article-title":"Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia because of 21-hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses","volume":"73","author":"Merc\u00e8 Fern\u00e1ndez-Balsells","year":"2010","journal-title":"Clinical Endocrinology"},{"key":"2017022117115972000_176.4.R167.99","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jpurol.2014.02.003","article-title":"Late prenatal dexamethasone and phenotype variations in 46,XX CAH: concerns about current protocols and benefits for surgical procedures","volume":"10","author":"Gorduza","year":"2014","journal-title":"Journal of Pediatric Urology"},{"key":"2017022117115972000_176.4.R167.100","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1324717"},{"key":"2017022117115972000_176.4.R167.101","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpurol.2010.01.001","article-title":"Congenital adrenal hyperplasia: Results of medical therapy on appearance of external genitalia","volume":"6","author":"Kulshreshtha","year":"2010","journal-title":"Journal of Pediatric Urology"},{"key":"2017022117115972000_176.4.R167.102","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"16","author":"Lo","year":"1997","journal-title":"Lancet"},{"key":"2017022117115972000_176.4.R167.103","doi-asserted-by":"publisher","DOI":"10.1002\/pd.219"},{"key":"2017022117115972000_176.4.R167.104","first-page":"1135","article-title":"Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency","volume":"101","author":"Bartha","year":"2003","journal-title":"Obstetrics and Gynecoly"},{"key":"2017022117115972000_176.4.R167.105","doi-asserted-by":"publisher","DOI":"10.1177\/1933719116632922"},{"key":"2017022117115972000_176.4.R167.106","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1118"},{"key":"2017022117115972000_176.4.R167.107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000439326","article-title":"Noninvasive prenatal diagnosis of congenital adrenal hyperplasia","volume":"30","author":"Khattab","year":"2016","journal-title":"Endocrine Development"},{"key":"2017022117115972000_176.4.R167.108","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.151U063"},{"key":"2017022117115972000_176.4.R167.109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000096353","article-title":"Prenatal diagnosis and treatment of congenital adrenal hyperplasia","volume":"67","author":"Nimkarn","year":"2007","journal-title":"Hormone Research"},{"key":"2017022117115972000_176.4.R167.110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2013.07.010","article-title":"Preparation characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model","volume":"15","author":"Ali","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"key":"2017022117115972000_176.4.R167.111","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.151U049"},{"key":"2017022117115972000_176.4.R167.112","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa032089","article-title":"Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity","volume":"25","author":"Yeh","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"2017022117115972000_176.4.R167.113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-3806(90)90002-G","article-title":"Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus","volume":"1","author":"Uno","year":"1990","journal-title":"Brain Research. Development Brain Research"},{"key":"2017022117115972000_176.4.R167.114","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68624-7"},{"key":"2017022117115972000_176.4.R167.115","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(94)00070-0"},{"key":"2017022117115972000_176.4.R167.116","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021129"},{"key":"2017022117115972000_176.4.R167.117","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0789"},{"key":"2017022117115972000_176.4.R167.118","doi-asserted-by":"crossref","first-page":"542548","DOI":"10.1210\/jc.2006-1340","article-title":"Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone","volume":"92","author":"Hirvikoski","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.119","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0280"},{"key":"2017022117115972000_176.4.R167.120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1651-2227.2011.02260.x","article-title":"Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study","volume":"100","author":"Hirvikoski","year":"1992","journal-title":"Acta Paediatrica"},{"key":"2017022117115972000_176.4.R167.121","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.yhbeh.2016.06.011","article-title":"Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH","volume":"85","author":"Wallensteen","year":"2016","journal-title":"Hormones and Behavior"},{"key":"2017022117115972000_176.4.R167.122","doi-asserted-by":"publisher","DOI":"10.1159\/000065490"},{"key":"2017022117115972000_176.4.R167.123","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020611"},{"key":"2017022117115972000_176.4.R167.124","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmh047"},{"key":"2017022117115972000_176.4.R167.125","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2631"},{"key":"2017022117115972000_176.4.R167.126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2012.10.885"},{"key":"2017022117115972000_176.4.R167.127","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.beem.2015.01.005","article-title":"Fetal endocrine therapy for congenital adrenal hyperplasia should not be done","volume":"29","author":"Miller","year":"2015","journal-title":"Best Practice and Research. Clinical Endocrinology and Metabolism"},{"key":"2017022117115972000_176.4.R167.128","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1222"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/176\/4\/R167.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/EJE-16-0888","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T00:52:54Z","timestamp":1719017574000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/176\/4\/R167\/6655092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":128,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/eje-16-0888","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}